cannabinol has been researched along with Chronic Insomnia in 1 studies
Cannabinol: A physiologically inactive constituent of Cannabis sativa L.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insomnia is the most prevalent sleep disorder, with few effective pharmacotherapies." | 3.30 | Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. ( D'Rozario, AL; Gordon, CJ; Grunstein, RR; Hoyos, CM; Irwin, C; Lavender, I; Marshall, N; McCartney, D; McGregor, I; Saini, B; Suraev, A; Yee, B, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lavender, I | 1 |
| McCartney, D | 1 |
| Marshall, N | 1 |
| Suraev, A | 1 |
| Irwin, C | 1 |
| D'Rozario, AL | 1 |
| Gordon, CJ | 1 |
| Saini, B | 1 |
| Grunstein, RR | 1 |
| Yee, B | 1 |
| McGregor, I | 1 |
| Hoyos, CM | 1 |
1 trial available for cannabinol and Chronic Insomnia
| Article | Year |
|---|---|
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.
Topics: Cannabinol; Humans; Polysomnography; Randomized Controlled Trials as Topic; Sleep; Sleep Initiation | 2023 |